MDCX Award Disclosure
Smith Andrew Alasdair · SEC Form 4 · Filed Sep 8, 2026
Award
Calculated transaction value
$0
Smith Andrew Alasdair Chief Operating Officer
MDCX
Medicus Pharma Ltd.
MDCX
Transaction date
Sep 4, 2026
Public filing date
Sep 8, 2026
Filing lag
Filed 4 days later
MDCX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (right to buy) on Common Shares
- Quantity / price
- 125,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0000950142-26-002522
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$125.37K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Medicus Pharma Ltd. MDCX | Award | Sep 4, 2026 | $125.37K |
| Medicus Pharma Ltd. MDCX Current | Award | Sep 4, 2026 | $0 |